πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Clinical Pipeline

United Therapeutics Europe Pipeline

All ClinicalTrials.gov programs at United Therapeutics Europe β€” phase, modality, and trial IDs.

Programs
336

Quick answer

United Therapeutics Europe has 336 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

  1. Vitamin A (retinyl palmitate)

    United Therapeutics Europe Ltd

    Vitamin A Deficiency

    phase 2 small molecule completed

    1 trial

  2. Vitamin D

    United Therapeutics Europe Ltd

    Breast Cancer

    phase 2 small molecule terminated

    1 trial

  3. Vitamin D3

    United Therapeutics Europe Ltd

    Parkinson Disease

    phase 2 other completed

    1 trial

  4. WBRT

    United Therapeutics Europe Ltd

    Bladder Cancer

    phase 2 other active

    1 trial

  5. WeCareAdvisor

    United Therapeutics Europe Ltd

    Dementia

    phase 2 other completed

    1 trial

  6. Whole cooked beans with rice meals

    United Therapeutics Europe Ltd

    Blood Glucose

    phase 2 other completed

    1 trial

  7. Yogurt smoothie with BB-12

    United Therapeutics Europe Ltd

    Metabolic Syndrome

    phase 2 small molecule active

    1 trial

  8. ZD6474

    United Therapeutics Europe Ltd

    Lung Cancer

    phase 2 small molecule completed

    2 trials

  9. Zonisamide

    United Therapeutics Europe Ltd

    Alcohol Dependence

    phase 2 small molecule completed

    1 trial

  10. Zonisamide 100Mg Cap

    United Therapeutics Europe Ltd

    Hearing Loss, Noise-Induced

    phase 2 small molecule terminated

    2 trials

  11. [11C]CPPC PET ligand

    United Therapeutics Europe Ltd

    ALS

    phase 2 small molecule active

    1 trial

  12. [123I] 5-IA

    United Therapeutics Europe Ltd

    Parkinson Disease

    phase 2 small molecule completed

    1 trial

  13. [123I]B-CIT

    United Therapeutics Europe Ltd

    Parkinson Disease

    phase 2 small molecule completed

    1 trial

  14. [123I]Ξ²-CIT

    United Therapeutics Europe Ltd

    Parkinson Disease

    phase 2 small molecule active

    1 trial

  15. abituzumab

    United Therapeutics Europe Ltd

    Metastatic Colorectal Cancer

    phase 2 small molecule terminated

    1 trial

  16. accelerated intermittent theta burst stimulation

    United Therapeutics Europe Ltd

    Long COVID

    phase 2 other active

    1 trial

  17. allogeneic human mesenchymal stem cells (hMSCs)

    United Therapeutics Europe Ltd

    Non-ischemic Dilated Cardiomyopathy

    phase 2 mab active

    1 trial

  18. amobarbital/Gel-One (one dose)

    United Therapeutics Europe Ltd

    Osteoarthritis

    phase 2 small molecule completed

    1 trial

  19. aspirin and atorvastatin

    United Therapeutics Europe Ltd

    Cardiovascular Risk Factor

    phase 2 small molecule active

    1 trial

  20. autologous skin fibroblasts

    United Therapeutics Europe Ltd

    Wounds and Injuries

    phase 2 mab active

    1 trial

  21. bevacizumab

    United Therapeutics Europe Ltd

    Colorectal Cancer

    phase 2 mab terminated

    1 trial

  22. bomedemstat

    United Therapeutics Europe Ltd

    Myelofibrosis

    phase 2 small molecule active

    1 trial

  23. cP12

    United Therapeutics Europe Ltd

    Thermal Burns

    phase 2 small molecule active

    1 trial

  24. ch14.18 -NCI

    United Therapeutics Europe Ltd

    Neuroblastoma

    phase 2 mab completed

    1 trial

  25. dovitinib lactate

    United Therapeutics Europe Ltd

    Gastrinoma

    phase 2 small molecule terminated

    1 trial

  26. emtricitabine/tenofovir alafenamide

    United Therapeutics Europe Ltd

    Acceptability of Health Care

    phase 2 small molecule completed

    1 trial

  27. everolimus

    United Therapeutics Europe Ltd

    Malignant Peripheral Nerve Sheath Tumors

    phase 2 small molecule completed

    1 trial

  28. ganetespib

    United Therapeutics Europe Ltd

    Malignant Peripheral Nerve Sheath Tumors (MPNST)

    phase 2 small molecule completed

    1 trial

  29. hyperbaric oxygen

    United Therapeutics Europe Ltd

    Breast Cancer

    phase 2 small molecule active

    1 trial

  30. iCasp9M28z T cell infusions

    United Therapeutics Europe Ltd

    Malignant Pleural Disease

    phase 2 gene therapy active

    1 trial

  31. ipatasertib

    United Therapeutics Europe Ltd

    Solid Tumor

    phase 2 small molecule active

    1 trial

  32. levodopa

    United Therapeutics Europe Ltd

    Parkinson Disease

    phase 2 small molecule completed

    1 trial

  33. nilotinib

    United Therapeutics Europe Ltd

    Mucosal Lentiginous Melanoma

    phase 2 small molecule completed

    1 trial

  34. oral treprostinil

    United Therapeutics Europe Ltd

    PAH

    phase 2 small molecule completed

    1 trial

  35. pUMVC3-IGFBP2-HER2-IGF1R Plasmid DNA Vaccine

    United Therapeutics Europe Ltd

    Anatomic Stage I Breast Cancer AJCC v8

    phase 2 mab active

    1 trial

  36. pemetrexed

    United Therapeutics Europe Ltd

    Lung Cancer

    phase 2 small molecule completed

    1 trial

  37. perindopril arginine

    United Therapeutics Europe Ltd

    Abdominal Aortic Aneurysm

    phase 2 small molecule completed

    1 trial

  38. plain crystalline niacin, exercise, sauna

    United Therapeutics Europe Ltd

    Gulf War Illness

    phase 2 small molecule completed

    1 trial

  39. pneumococcal polysaccharide and protein conjugate vaccines

    United Therapeutics Europe Ltd

    Pneumococcal Infections

    phase 2 mab completed

    1 trial

  40. pregabalin

    United Therapeutics Europe Ltd

    Pain

    phase 2 small molecule completed

    1 trial

  41. rF1V-1018

    United Therapeutics Europe Ltd

    Plague, Pneumonic

    phase 2 mab completed

    1 trial

  42. rF1V-1018

    United Therapeutics Europe Ltd

    Prevention of Pneumonic Plague Resulting From Aerosol Exposure to Yersenia Pestis

    phase 2 mab active

    1 trial

  43. rituximab

    United Therapeutics Europe Ltd

    Lymphoma

    phase 2 mab completed

    1 trial

  44. sublingual nitroglycerine

    United Therapeutics Europe Ltd

    COLIC

    phase 2 small molecule active

    1 trial

  45. treprostinil dienthanolmine sustained release

    United Therapeutics Europe Ltd

    Critical Limb Ischemia

    phase 2 small molecule completed

    1 trial

  46. treprostinil diethanolamine

    United Therapeutics Europe Ltd

    Systemic Sclerosis

    phase 2 small molecule completed

    2 trials

  47. trihexyphenidyl

    United Therapeutics Europe Ltd

    Dystonia

    phase 2 small molecule completed

    1 trial

  48. zinc supplementation

    United Therapeutics Europe Ltd

    HIV Infections

    phase 2 small molecule completed

    1 trial

Frequently asked questions

How many pipeline programs does United Therapeutics Europe have?

336 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Data attribution: Data sources Β· All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates β€” weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.